Chemical Bank lowered its position in Aetna Inc (NYSE:AET) by 7.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,134 shares of the company’s stock after selling 3,557 shares during the period. Aetna comprises 0.9% of Chemical Bank’s holdings, making the stock its 23rd largest position. Chemical Bank’s holdings in Aetna were worth $8,141,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Farallon Capital Management LLC acquired a new position in Aetna in the 4th quarter worth $940,734,000. Deutsche Bank AG boosted its stake in Aetna by 57.5% in the 4th quarter. Deutsche Bank AG now owns 2,704,723 shares of the company’s stock worth $487,900,000 after purchasing an additional 987,156 shares during the period. Alpine Associates Management Inc. acquired a new position in Aetna in the 4th quarter worth $159,933,000. Amundi Pioneer Asset Management Inc. boosted its stake in Aetna by 1,087.9% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 926,948 shares of the company’s stock worth $167,213,000 after purchasing an additional 848,913 shares during the period. Finally, Hudson Bay Capital Management LP boosted its stake in Aetna by 462.4% in the 4th quarter. Hudson Bay Capital Management LP now owns 845,810 shares of the company’s stock worth $152,576,000 after purchasing an additional 695,428 shares during the period. Institutional investors and hedge funds own 87.25% of the company’s stock.
AET has been the subject of a number of research analyst reports. Morgan Stanley lowered shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price for the company. in a research note on Wednesday, December 20th. Credit Suisse Group reaffirmed a “neutral” rating and issued a $195.00 target price (up from $174.00) on shares of Aetna in a research note on Wednesday, December 6th. Argus lowered shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price for the company. in a research note on Wednesday, December 6th. Wells Fargo reaffirmed an “outperform” rating and issued a $208.00 target price (up from $200.00) on shares of Aetna in a research note on Monday, December 4th. Finally, ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Nine research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Aetna currently has an average rating of “Buy” and a consensus price target of $189.50.
Aetna Inc (AET) opened at $169.45 on Friday. Aetna Inc has a one year low of $124.84 and a one year high of $194.40. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.65 and a current ratio of 0.65. The company has a market cap of $55,583.49, a PE ratio of 17.30, a PEG ratio of 1.37 and a beta of 0.65.
Aetna (NYSE:AET) last issued its earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The business had revenue of $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. During the same period last year, the business posted $0.08 EPS. Aetna’s revenue was down 6.2% on a year-over-year basis. research analysts anticipate that Aetna Inc will post 11.06 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, April 12th will be paid a $0.50 dividend. The ex-dividend date is Wednesday, April 11th. This represents a $2.00 annualized dividend and a yield of 1.18%. Aetna’s dividend payout ratio (DPR) is currently 34.78%.
ILLEGAL ACTIVITY NOTICE: This report was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://ledgergazette.com/2018/03/23/aetna-inc-aet-position-lowered-by-chemical-bank.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.